Transition of stable pediatric patients with pulmonary arterial hypertension from intravenous epoprostenol to intravenous treprostinil.
about
Drug treatment of pulmonary hypertension in childrenPharmacotherapy for pulmonary hypertensionPulmonary arterial hypertension: a comparison between children and adultsRecent progress in understanding pediatric pulmonary hypertensionPulmonary Hypertension in Children.Initial experience with tadalafil in pediatric pulmonary arterial hypertension.Pediatric pulmonary arterial hypertension.Prostacyclin in the intensive care setting.Medical therapy for pediatric pulmonary arterial hypertensionNon-congenital heart disease associated pediatric pulmonary arterial hypertensionPulmonary hypertension in bronchopulmonary dysplasiaAdvances in pediatric pulmonary arterial hypertension.A New Era in Medical Management of Severe Pediatric Pulmonary Arterial Hypertension.Acute pulmonary vasodilator testing with inhaled treprostinil in children with pulmonary arterial hypertension.Pediatric Cardiac Intensive Care Society 2014 Consensus Statement: Pharmacotherapies in Cardiac Critical Care Pulmonary Hypertension.Treatment of pediatric pulmonary hypertensionCurrent challenges in pediatric pulmonary hypertension.Advances in therapies for pediatric pulmonary arterial hypertension.Pediatric pulmonary arterial hypertension: current and emerging therapeutic options.Optimal use of treprostinil in pulmonary arterial hypertension: a guide to the correct use of different formulations.An update on medical therapy for pulmonary arterial hypertension.Advances in paediatric pulmonary vascular disease associated with bronchopulmonary dysplasia.Treating pulmonary hypertension in pediatrics.Transition from intravenous or subcutaneous prostacyclin therapy to inhaled treprostinil in patients with pulmonary arterial hypertension: a retrospective case series.Diagnosis, Evaluation and Treatment of Pulmonary Arterial Hypertension in Children.
P2860
Q26996078-EBFDD59F-6E23-449B-BEB1-59ACC828C704Q27022763-D0204562-4F71-4B4E-8808-0845AFB193B4Q27687320-F1E38165-B26B-4FC5-B23D-F1691A97EF1DQ27691453-DBA84600-2B15-481B-89AF-AE6D2FDCBFA5Q30248871-6D55223C-8FDA-42A4-99F1-CFC4422B9A37Q33161066-3D1B92A4-1FE2-43EC-9B7D-4667EA27AFF2Q33163446-3380FD46-100C-4395-A5BE-6F9DE53D48DAQ35050464-2010A61B-EDE0-478E-82E5-05157038EFC8Q35079604-82E77BEB-E147-4FA5-A70F-DE6BE4D381D6Q35165691-3D1A246C-0F31-4404-86A2-E7290A4CE9E7Q35731631-4848C3BB-3B49-4618-919D-52A08A8BD8D4Q35869437-092BE5EC-F85C-41C9-888F-065CE2ADC12DQ36481525-C6910A93-C3B1-421B-B5BF-3426B1455C5DQ36718346-DED8A2BD-17A8-407F-917D-959C95DF639DQ36763080-91B4ED1C-3C12-486F-9287-2C1023E0753EQ37230469-7252D95B-166C-45CB-90E6-F9BD76997400Q37540613-A73C5DE7-A6A8-4392-866D-8F374EBA9ED8Q37755020-61B05B9D-12C7-49DB-A1A5-20EC7209E5DDQ37879213-7CEC27D1-6DA7-4498-B81F-B16DC1D5454FQ38066529-CB215E53-1665-4520-B393-A542C4CA02FBQ38152292-674B0911-3161-4FBD-AD25-4DB480F2146FQ38271628-EBD72383-2879-42A2-8C88-EE143D0AFDF4Q38349395-02091F53-6655-4E9F-9CEB-440E8232E18CQ45363251-5E16CE45-D961-412B-93FF-64BA4A543D32Q55001904-A0111B4D-D2AB-4744-8C1C-FDBE888F11A7
P2860
Transition of stable pediatric patients with pulmonary arterial hypertension from intravenous epoprostenol to intravenous treprostinil.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Transition of stable pediatric ...... l to intravenous treprostinil.
@ast
Transition of stable pediatric ...... l to intravenous treprostinil.
@en
type
label
Transition of stable pediatric ...... l to intravenous treprostinil.
@ast
Transition of stable pediatric ...... l to intravenous treprostinil.
@en
prefLabel
Transition of stable pediatric ...... l to intravenous treprostinil.
@ast
Transition of stable pediatric ...... l to intravenous treprostinil.
@en
P2093
P2860
P1476
Transition of stable pediatric ...... l to intravenous treprostinil.
@en
P2093
Aimee Doran
D Dunbar Ivy
Lori Claussen
P2860
P304
P356
10.1016/J.AMJCARD.2006.09.119
P407
P577
2007-01-10T00:00:00Z